Document is current
Any future updates will be listed below
-
Authors
Erbay, Muhammed Ibrahim
Manubolu, Venkat Sanjay
Stein-Merlob, Ashley F.
Ferencik, Maros
Mamas, Mamas A.
Lopez-Mattei, Juan
Baldassarre, Lauren A.
Budoff, Matthew J.
Yang, Eric H.
- License Information
-
More Information
Article History
Accepted: 24 January 2025
First Online: 11 February 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Maros Ferencik: Consulting: Siemens Healthineers, Elucid, HeartFlow, Cleerly, BioMarin; Advisory board: Cleerly; Stock options: Elucid. Matthew J. Budoff: Received grants from the following companies: Novo Nordisk, Novartis, AstraZeneca, HeartFlow, GE Healthcare, Amgen, and Boehringer Ingelheim, Department of Defense, Centers for Disease Contral, and the National Institutes of Health. Dr Budoff received honoraria from Novo Nordisk, Esperion, AstraZeneca, Merck, Janssen, and Eli Lilly. Eric H. Yang: Research funding/grants: CSL Behring, Boehringer Ingelheim, Eli and Lilly, Amgen, Bristol Myers Squibb, and Janssen Research and Development (all nonrelevant). Consulting fees: Xencor (nonrelevant) and Edwards Lifesciences. Speaker honoraria: Zoll Medical (nonrelevant) and National Cancer Comprehensive Cancer Center. The other authors declare that they have no conflict of interest.
